Sarah Jessica Parker cuts ties with Mylan over pricing controversy; lung-cancer physicians turn to Keytruda; Merck KGaA diversifies its business
Mylan offers additional copay assistance for EpiPen amid criticism; fewer doctors are seeing reps; two Copaxone patents are invalidated
The drugmaker expects the multi-channel initiative to lay its foundation in the ophthalmology market.
The anti-tobacco movement Truth is hitting young people in their pocketbooks with a new spot called "Squadless."
Retzlaff files a complaint against Turing; Pfizer to buy antibiotics from AstraZeneca; Mylan's marketing for EpiPen faces criticism
Grassley blasts Mylan over EpiPen price increases; Portola Pharmaceuticals receives CRL letter for reversal agent; the FDA approves Pfizer's opioid
Pfizer's commercial expertise in urology and oncology could help propel Medivation's Xtandi to new heights.
Pfizer to acquire cancer drugmaker Medivation; Valeant names new CFO; Apple acquires health data startup
The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.
Another study finds doctors who receive gifts from drugmakers prescribe their drugs; Part D spending rose 17% in 2014; Mallinckrodt to open New Jersey site
Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.
Court clears Pfizer to move ahead with Remicade biosimilar; McDonald's yanks activity trackers over skin irritation; California drug-pricing bill pulled
AHIP study says half of orphan-drug usage is for non-orphan indications; Studies of GSK weight-loss pill underestimated side effects; ViiV starts HIV trial
The health site had a 44% increase in unique visitors in July 2016, compared to the same month a year ago.
The Cleveland Clinic has launched its first national men's health campaign, MENtion It, to encourage men to be more proactive about their health.
A new study published in JAMA said PCSK9 inhibitors are not worth their high prices.
OncoGenex's prostate cancer drug fails in clinical trial; Aetna to exit exchanges in 11 states; pregnant women taking acetaminophen have higher risks for their children
PhRMA and BIO, which represent life sciences firms, developed principles about sharing truthful and non-misleading information with payers and providers.
Bayer recently tapped Ken Griffey Sr. and Ken Griffey Jr. — the first father-son duo to be inducted into the Baseball Hall of Fame — as spokespeople.
Agencies are testing out strategies to reach gender parity at a time when questions of discrimination are still front and center.
Express Scripts does not disclose names of formulary board members; Endo withdrew abuse-deterrent formulation for opioid; BI to collect real-world data on Praxbind
Critics say the direct-to-consumer ad for the immuno-oncology therapy is misleading.
The company's first global consumer CMO shares the challenges of delivering global campaigns and meeting local market needs.
Study finds estimated drug costs are often overstated; physician criticizes DTC ad for Opdivo; Merck HPV ads are criticized for being manipulative
Valeant is under federal investigation; Lilly's breast-cancer drug fails to meet efficacy criteria; new policy opens up medical research of marijuana
The impending payer crackdown of the cost of MS drugs could portend the fate of other specialty drug markets, according to analysts.
Lynn Fox is suing W2O. She was laid off in March, seven months after the agency network bought her San Francisco-based boutique, Fox Communications.
A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion
Valeant had deployed roughly 100 additional sales reps this year to promote Xifaxan's indication in hepatic encephalopathy.
The companies said they are also exploring opportunities to allow Cleveland Clinic experts to contribute to Verywell in the future.
Novo Nordisk attributes slow growth to biosimilars, pricing; Dentsu acquires majority stake in Merkle; AZ lung cancer drug fails late-stage trial
A massive disappointment for Bristol-Myers Squibb's Opdivo in first-line lung cancer has leveled the playfield for Merck's Keytruda.
Valeant reorganizes executive team; experimental asthma drug developed by Novartis shows promising results; Teva launches generic Gleevec
The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.
Opdivo fails to meet endpoint in new lung cancer patients; abuse-deterrent drug gets nod from FDA panel; Cephalon settles pay-for-delay case
The campaign will run in an integrated digital marketing format using channels such as Facebook, Twitter, and Youtube.
Researchers test Zika vaccine; Aetna contacts doctors who prescribe high rates of opioids; half of pediatric trials are never published or completed
The popular fitness tracker maker hired Adam Pellegrini, Walgreens' VP of digital health, to boost pharma and healthcare deals.
Express Scripts and CVS Health revealed their formularies with Pfizer's Xeljanz making the jump from excluded to preferred for Express Scripts.
Merck and Allergan reportedly vying to buy Biogen; drugmakers fight California measure capping drug prices; few seniors use the web to look for health info
The company launched a health watch, a connected scale, a blood pressure monitor, and a thermometer.
He resigned as Saatchi & Saatchi's executive chairman following his controversial remarks over gender diversity.
IBM develops chip to detect early stages of cancer; Theranos plans to develop a "minilab;" Aetna and Humana to sell $117 million in assets
MM&M's 2016 Hall of Femme honorees talk about who inspires them, describe their "Raphael moments," and share their experiences as women leaders.
Here's everything you missed or may want to revisit from MM&M's inaugural Hall of Femme event in June.
The reaction from social media was swift and brutal, with figures from all levels of the advertising industry blasting Roberts for his comments.
By focusing on accomplished people, the campaign is meant to show that addiction isn't a moral failing, but a physical condition that requires medical help.
GSK partners with Google to create joint venture; Philips Healthcare launches a health watch; Advent invests in inVentiv Health
England's NHS delays hep-C coverage due to pricing; Google reports 21% revenue growth; U.S. and U.K. announce partnership for antibiotic development
Vertex says Orkambi is on the blockbuster track; Advent and CVC reportedly made offers to buy inVentiv Health; the FDA approves Sanofi's Adlyxin
She will be responsible for the medical device practice's strategy and operations across all W2O Group agencies.
IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire
Sales of Gilead's HCV drugs fall; the DNC policy platform criticized price gouging; Janssen partners with Bristol-Myers Squibb on Opdivo combo drug
Red, a Huntsworth agency, also counted Sanofi as a new client.
The nonprofit is dedicated to curing blood cancer.
Now that it has consolidated its global agency roster, GSK Consumer Healthcare aims to increase digital marketing efforts.
Darzalex may interfere with blood testing; Kaine scrutinized for ties to pharma; medical societies are in support of bill exempting CME reporting
Herceptin biosimilar meets endpoint in clinical trial; Roche plans to launch five new drugs over the next year; government seeks to block insurer deals
The drugmaker had launched the campaign for the multiple sclerosis drug in 2015.
The FDA approves generic versions of AstraZeneca's Crestor; Biogen CEO steps down; drugmakers race to develop smart inhalers
Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger
One oft-cited challenge to Entresto's adoption has been prior authorization requirements.
Twenty shops, including Co:Collective, Wolff Olins, and 72andSunny, have signed onto the Pledge Parental Leave coalition since March.
The FDA declines to approve Novartis biosimilar; GSK partners with Apple's ResearchKit; drugmakers partner with Lyft for clinical trial participants
Mehr was recently promoted to lead customer-centric marketing solutions at ZS Associates.
Roche's blood cancer drug fails to meet trial goal; the FDA says Valeant's psoriasis drug carries risk of suicide; Facebook tests disappearing messages
The health technology company's EVP of business growth and analytics talks about his career path, from studying medicine to leading ContextMedia:Health's commercial solutions team.
PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit
Scheiner has held jobs in and out of healthcare over the course of his career.
The FDA expands use for Pfizer's Prevnar 13 vaccine; an FDA panel votes in support of Novartis biosimilar; U.S. healthcare spending rises 5.5% in 2015
Globally, digital ad spend this year is expected to grow by 12.6% to $176.7 billion, accounting for 32% of all ad spend.
Gilead reportedly avoiding paying billions in taxes; Merck plans to cut R Sage's treatment for postpartum depression meets trial goal
The partnership is aimed at helping later-stage health startups grow their businesses with marketing and brand strategy advice.
U.S. cancer centers triple spending on advertising; study finds patient choice can reduce side effects; the FDA approves Shire's dry-eye drug
He is replacing Martin Golden, who was appointed head of global marketing strategy.
Purdue Pharma reportedly knew about OxyContin trafficking; Amgen's Repatha approved for monthly dosing option; Clinton proposes new healthcare measures
Work created by the FCB Health network and Ogilvy CommonHealth Worldwide named among the finalists for the 2016 MM&M Awards.
Prounis sold her stake in Flashpoint to Omnicom, which is merging the agency with four other shops to create DDB Health.
The FDA said Amgen's biosimilar of Humira is safe and effective; Juno trial halted due to patient deaths; the CMS bans Theranos founder
Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.
EpiPen price hikes led to syringe use; states with medical marijuana laws have drops in drug spending; Pfizer and Merck KGaA start ovarian cancer trial
Pfizer to disclose addiction risk in promo materials for opioids; Medivation considers an acquisition; Almirall expresses interest in buying Valeant drugs
U.S. companies accounted for nearly a quarter of the startups funded to celebrate Publicis' 90th anniversary.
States and insurers are lifting restrictions on HCV drugs; Teva's request to join PhRMA raises eyebrows; Merck partners with GPO
Ogilvy CommonHealth Worldwide, FCB Health, and McCann Health North America are North America's biggest healthcare agencies, based on 2015 revenue.
Drugmakers doled out $452 million to UK healthcare providers; GSK, Pfizer see big market in vaccines for expectant mothers; Shire ADHD drug meets endpoint
BI axes 725 U.S. jobs; Bill Gates supports current U.S. drug pricing; drugmakers are targeting smaller hospitals
Global tech PR agency Hotwire has launched a global health tech practice, overseen from London by group chief development officer Andy West.
Help us compile the most accurate and meaningful picture of salaries, job satisfaction, and trends in the healthcare market. And be entered to win one of three $200 AmEx gift cards.
GIlead Sciences' new HCV treatment receives approval; FDA adcomm votes in favor of Jardiance health-outcomes' claims; FDA names head of new oncology center
The new healthcare network combines several US and European professional agencies, Omnicom said.
Opdivo nets sixth Breakthrough Therapy designation; AstraZeneca seeks rare indication to block Crestor generics; Endo mulls sale to reduce debt
Tactics like a talking bear were employed to engage the LGBTQ community and millennials, along with a tagline promoting self-expression.
Former FDA commissioners said agency should be independent from HHS; Sanofi and BI confirm asset swap; FDA panel to vote on new Jardiance data
Brexit votes creates EU regulatory uncertainty; Obama plans to veto health saving accounts bill; broad Entresto adoption could prevent more than 28,000 deaths
Medicare cost-cutting panel will not be activated this year; more Americans are abusing opioids; BIO blasts ICER
David Paragamian, previously of Huntsworth Health, is the new managing director of Razorfish Health.
Mr. Sun serves as a follow-up to last year's social media campaign Free Killer Tan, and looks to encourage "UV-smart behaviors" among parents.
Women use apps to get prescriptions for birth control; BMS names Gordon to chief commercial role; Takeda's Actos may halt progression of liver disease;
The agency has hired Sally Barton as head of the U.S. healthcare practice/
- Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market
- Five things for pharma marketers to know: Tuesday, August 23, 2016
- Five things for pharma marketers to know: Monday, August 22, 2016
- Five things for pharma marketers to know: Wednesday, August 24, 2016
- 3 Lessons on Behavior Change from Pokémon Go
- Boehringer Ingelheim launches gamified support program
- Leadership Exchange: Engaging the Millennial Doctor
- Klick opens NY office with slew of agency 'rock stars'
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- The co-pay card debate simmers, as payers push back
- Five things for pharma marketers to know: Friday, August 26, 2016
- Five things for pharma marketers to know: Thursday, August 25, 2016
- Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market
- Anti-smoking group Truth releases musical FOMO spot for MTV Video Music Awards